Repligen (RGEN) Change in Accured Expenses (2010 - 2026)

Repligen (RGEN) has reported Change in Accured Expenses for 17 consecutive years, with $12.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Accured Expenses rose 352.56% year-over-year to $12.1 million in Q2 2026; TTM through Jun 2026 was $14.3 million, a 1576.17% increase from a year earlier, with the FY2025 full-year figure at $11.8 million, up 93.47% from the prior year.
• Change in Accured Expenses was $12.1 million for Q2 2026 at Repligen, up from -$12.7 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $12.6 million in Q3 2025 and troughed at -$12.7 million in Q1 2026.
• A 5-year average of -$341388.9 and a median of $12500.0 in 2024 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses surged 516.24% in 2024 and plunged 800.33% in 2026, its largest moves.
• Over 5 years, Change in Accured Expenses stood at -$5.1 million in 2022, then sank by 77.87% to -$9.0 million in 2023, then soared by 108.29% to $746000.0 in 2024, then jumped by 192.76% to $2.2 million in 2025, then surged by 455.31% to $12.1 million in 2026.
• The last three Change in Accured Expenses figures came in at $12.1 million (Q2 2026), -$12.7 million (Q1 2026), and $2.2 million (Q4 2025), per Business Quant data.